Dr. Umut Sarpel 

Surgical Oncology doctor
Mt. Sinai
New York, NY 10029
View Contact Information

Schedule a Conversation with a HIPEC Surgeon

The surgeon or staff member will make their best effort to call you at your requested time. If they become unavailable you will receive a text.

Fill out my online form.

Board Certified

Board certification by an ABMS Member Board is the premier, independently assessed credential attainable in medicine today.

Dr. Umut Sarpel is affiliated with Mt. Sinai.

Fellowship Experience

Mount Sinai Hospital

Additional Information

Umut Sarpel, MD, MSc, is a board-certified Surgeon who specializes in Surgical Oncology. She earned her medical degree from the State University of New York at Buffalo and completed her residency in General Surgery at The Icahn School of Medicine at Mount Sinai. Dr. Sarpel then pursued an additional two years of specialty training in the field of Surgical Oncology while attaining a Master of Science in Clinical Research. She is a Fellow of the American College of Surgeons, and a member of the Society of Surgical Oncology, the American HepatoPancreatoBiliary Association, and the International Liver Cancer Association.

Dr. Sarpel specializes in the care of patients with cancers of the stomach, pancreas, liver, biliary tree, small bowel, and colon, as well as sarcoma and melanoma. Her practice includes both open and minimally invasive cancer surgery, including laparoscopic pancreatectomy, laparoscopic liver resection, and laparoscopic colectomy. In addition, she performs Heated Intraperitoneal Chemotherapy (HIPEC) for the treatment of carcinomatosis, and offers laparoscopic HIPEC for certain cases.

Dr. Sarpel conducts clinical and outcomes research and has published several articles in the fields of surgical oncology, hepatobiliary surgery, and healthcare disparities. She is the recipient of a prestigious National Cancer Institute grant to investigate the disparities in the treatment of Hepatocellular Carcinoma. Dr. Sarpel is also strongly committed to medical education and has been honored with multiple teaching awards, such as the Medical Student Teaching Award in Surgery, the House Staff Award for Excellence in Teaching, and the Humanism and Excellence in Teaching Award. She is the author of “Surgery; An Introductory Guide” a book for medical students. A compelling story of Dr. Sarpel with one of her patients was recently featured in the book "Twelve Patients.”

Her publications on HIPEC include:

· Prophylactic hyperthermic intraperitoneal chemotherapy in patients with epithelial appendiceal neoplasms. Tuvin D, Berger Y, Aycart SN, Shtilbans T, Hiotis S, Labow DM, Sarpel U. Int J Hyperthermia. 2016 May;32(3):311-5.

· Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with liver involvement. Berger Y, Aycart S, Tabrizian P, Agmon Y, Mandeli J, Heskel M, Hiotis S, Sarpel U, Labow DM. J Surg Oncol. 2016 Mar;113(4):432-7.

· Extreme cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: Outcomes from a single tertiary center. Berger Y, Aycart S, Mandeli JP, Heskel M, Sarpel U, Labow DM. Surg Oncol. 2015 Sep;24(3):264-9.

· Incorporation of diagnostic laparoscopy in the management algorithm for patients with peritoneal metastases: A multi-institutional analysis. Tabrizian P, Jayakrishnan TT, Zacharias A, Aycart S, Johnston FM, Sarpel U, Labow DM, Turaga KK. J Surg Oncol. 2015 Jun;111(8):1035-40.

· Escalation of socioeconomic disparities among patients with colorectal cancer receiving advanced surgical treatment. Tabrizian P, Overbey J, Carrasco-Avino G, Bagiella E, Labow DM, Sarpel U. Ann Surg Oncol. 2015 May;22(5):1746-50.

· Outcome of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy on patients with diaphragmatic involvement. Franssen B, Tabrizian P, Weinberg A, Romanoff A, Tuvin D, Labow D, Sarpel U. Ann Surg Oncol. 2015 May;22(5):1639-44.

· Cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy in patients with peritoneal hepatocellular carcinoma. Tabrizian P, Franssen B, Jibara G, Sweeney R, Sarpel U, Schwartz M, Labow D. J Surg Oncol. 2014 Dec;110(7):786-90.

· Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis: outcomes from a single tertiary institution. Tabrizian P, Shrager B, Jibara G, Yang MJ, Romanoff A, Hiotis S, Sarpel U, Labow DM. J Gastrointest Surg. 2014 May;18(5):1024-31.

· Genitourinary resection at the time of cytoreductive surgery and heated intraperitoneal chemotherapy for peritoneal carcinomatosis is not associated with increased morbidity or worsened oncologic outcomes: a case-matched study. Leapman MS, Jibara G, Tabrizian P, Franssen B, Yang MJ, Romanoff A, Hall SJ, Palese M, Sarpel U, Hiotis S, Labow D. Ann Surg Oncol. 2014 Apr;21(4):1153-8.

· Outcomes for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the elderly. Tabrizian P, Jibara G, Shrager B, Franssen B, Yang MJ, Sarpel U, Hiotis S, Labow D. Surg Oncol. 2013 Sep;22(3):184-9.

· The development of a peritoneal surface malignancy program: a tale of three hospitals. Sarpel U, Melis M, Newman E, Pachter HL, Berman RS. J Cancer Educ. 2012 Dec;27(4):670-5.